问答：Eric Winer 谈新辅助临床试验

Q&A: Eric Winer on neoadjuvant clinical trials.

出版信息

Cancer Discov. 2013 Aug;3(8):832. doi: 10.1158/2159-8290.CD-ND2013-017. Epub 2013 Aug 1.

DOI:10.1158/2159-8290.CD-ND2013-017

Abstract

Eric Winer, MD, professor of medicine at Harvard Medical School and director of the Breast Oncology Center at Dana-Farber Cancer Institute, discusses presurgical trials for breast cancer and the roles such trials may eventually play in drug approvals.

摘要

哈佛医学院医学教授、达纳-法伯癌症研究所乳腺肿瘤中心主任 Eric Winer，医学博士，讨论了乳腺癌的术前试验以及此类试验最终在药物批准中可能发挥的作用。